GENOMMA LAB INTERNACIONAL SABGENOMMA LAB INTERNACIONAL SABGENOMMA LAB INTERNACIONAL SAB

GENOMMA LAB INTERNACIONAL SAB

No trades
See on Supercharts
Market capitalization
‪14.36 B‬MXN
‪1.03 B‬MXN
‪16.47 B‬MXN
‪709.29 M‬
Beta (1Y)
0.54

About GENOMMA LAB INTERNACIONAL SAB

CEO
Marco Sparvieri
Headquarters
Mexico City
Employees (FY)
‪1.59 K‬
Founded
1996
ISIN
MX01LA010006
FIGI
BBG000G12N97
Genomma Lab Internacional SAB de CV engages in the development, manufacturing and marketing of pharmaceutical, beauty and personal care products. The company was founded by Rodrigo Alonso Herrera Aspra on October 30, 1996 and is headquartered in Mexico City, Mexico.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of LAB/B is 14.64 MXN — it has increased by 0.41% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange GENOMMA LAB INTERNACIONAL SAB stocks are traded under the ticker LAB/B.
GENOMMA LAB INTERNACIONAL SAB is going to release the next earnings report on Apr 24, 2024. Keep track of upcoming events with our Earnings Calendar.
LAB/B stock is 1.87% volatile and has beta coefficient of 0.54. Check out the list of the most volatile stocks — is GENOMMA LAB INTERNACIONAL SAB there?
One year price forecast for GENOMMA LAB INTERNACIONAL SAB has a max estimate of 25.00 MXN and a min estimate of 16.00 MXN.
LAB/B earnings for the last quarter are −0.12 MXN per share, whereas the estimation was 0.42 MXN resulting in a −127.98% surprise. The estimated earnings for the next quarter are 0.20 MXN per share. See more details about GENOMMA LAB INTERNACIONAL SAB earnings.
GENOMMA LAB INTERNACIONAL SAB revenue for the last quarter amounts to ‪4.39 B‬ MXN despite the estimated figure of ‪4.33 B‬ MXN. In the next quarter revenue is expected to reach ‪3.79 B‬ MXN.
Yes, you can track GENOMMA LAB INTERNACIONAL SAB financials in yearly and quarterly reports right on TradingView.
LAB/B stock has fallen by 5.55% compared to the previous week, the month change is a 0.07% fall, over the last year GENOMMA LAB INTERNACIONAL SAB has showed a 1.28% decrease.
LAB/B net income for the last quarter is ‪−115.50 M‬ MXN, while the quarter before that showed ‪370.67 M‬ MXN of net income which accounts for −131.16% change. Track more GENOMMA LAB INTERNACIONAL SAB financial stats to get the full picture.
Today GENOMMA LAB INTERNACIONAL SAB has the market capitalization of ‪14.87 B‬, it has increased by 2.46% over the last week.
GENOMMA LAB INTERNACIONAL SAB dividend yield was 4.15% in 2023, and payout ratio reached 54.47%. The year before the numbers were 3.41% and 41.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, LAB/B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOMMA LAB INTERNACIONAL SAB stock right from TradingView charts — choose your broker and connect to your account.
LAB/B reached its all-time high on Dec 2, 2013 with the price of 40.07 MXN, and its all-time low was 3.25 MXN and was reached on Mar 17, 2009.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has ‪1.59 K‬ employees. See our rating of the largest employees — is GENOMMA LAB INTERNACIONAL SAB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOMMA LAB INTERNACIONAL SAB technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOMMA LAB INTERNACIONAL SAB stock shows the sell signal. See more of GENOMMA LAB INTERNACIONAL SAB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GENOMMA LAB INTERNACIONAL SAB future price: according to them, LAB/B price has a max estimate of 25.00 MXN and a min estimate of 16.00 MXN. Read a more detailed GENOMMA LAB INTERNACIONAL SAB forecast: see what analysts think of GENOMMA LAB INTERNACIONAL SAB and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENOMMA LAB INTERNACIONAL SAB EBITDA is ‪3.48 B‬ MXN, and current EBITDA margin is 21.14%. See more stats in GENOMMA LAB INTERNACIONAL SAB financial statements.